The vaccine pipeline is outpacing the US Centers for Disease Control and Prevention’s ability to review the products, a situation that could present challenges for future coverage and reimbursement of new products.
Key Takeaways
-
The CDC’s top ACIP concern is that its workload is growing faster than its membership.
-
The ACIP will not...
CDC’s Associate Director for Vaccine Policy Melinda Wharton said she is very concerned about the mismatch between the number of Advisory Committee on Immunization Practices members and the growing vaccine...